Before you start this medication, consider discussing the following with a healthcare provider: Use retatrutide only under a clinicians supervision, since data on its long-term safety is still incomplete
Topline Eli Lilly, the GLP-1 maker behind Mounjaro and Zepbound, said it would file for Food and Drug Administration approval of its powerful retatrutide weight-loss drug after studies found participants lost an average of nearly 56 pounds after 80 weeks on the medication
Information about data access request proposals can be found at Change history 28 May 2024 In the version of the article initially published, in Fig
Metabolic-bariatric surgery reduces pancreatic cancer risk: a meta-analysis of over 3.7 million adults, independent of type 2 diabetes status
Detailed guidance on what to eat on tirzepatide and the best foods for GLP-1 users can help optimize outcomes across all the benefit categories discussed in this guide
These might include stress, diet, physical activity, sleep, medications, and more